IRulya Therapeutics Inc.
IRLANasdaqCIK 1662774HealthcareFiscal year ends Dec 31
Reports and events: 127 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1912:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-424731 |
| 2026-10-0911:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-418538 |
| 2026-10-0620:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-415730 |
| 2026-10-0211:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-411260 |
| 2026-09-1420:30 ET | 8-K | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-390652 |
| 2026-09-0412:30 ET | 8-K | 3.01 Delisting notice | 0001193125-26-382838 |
| 2026-08-2720:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-371389 |
| 2026-08-2512:30 ET | DEF 14A | Proxy statementPeriod 2026-10-06 | 0001193125-26-364220 |
| 2026-08-1710:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-353141 |
| 2026-08-1420:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-352201 |
| 2026-08-1412:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-350568 |
| 2026-07-3120:50 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-328784 |
| 2026-07-3010:02 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-324786 |
| 2026-06-2620:31 ET | 8-K/A | 3.03 Change to security holders’ rights | 0001193125-26-285572 |
| 2026-06-2613:18 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-284089 |
| 2026-06-1121:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-267862 |
| 2026-05-2121:06 ET | 8-K | 8.01 Other events | 0001193125-26-234858 |
| 2026-05-1820:20 ET | 8-K/A | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-228956 |
| 2026-05-1813:33 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-228133 |
| 2026-05-1121:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-217098 |
| 2026-04-2820:30 ET | 8-K | 8.01 Other events | 0001193125-26-187243 |
| 2026-04-2720:39 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001193125-26-182255 |
| 2026-04-2220:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-170572 |
| 2026-04-1020:35 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-151364 |
| 2026-04-0913:23 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-149021 |
| 2026-03-3012:35 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-130489 |
| 2026-03-2020:45 ET | 8-K | 3.01 Delisting notice | 0001193125-26-117794 |
| 2026-02-1211:06 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001193125-26-047544 |
| 2026-02-0221:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-033758 |
| 2026-01-2921:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-029524 |
| 2025-11-1221:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-277529 |
| 2025-11-1221:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-277523 |
| 2025-10-1720:11 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-25-242514 |
| 2025-09-2620:45 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-25-220722 |
| 2025-08-1120:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106535 |
| 2025-08-1120:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106536 |
| 2025-07-1620:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-159886 |
| 2025-06-1321:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-140873 |
| 2025-06-0520:12 ET | 8-K | 5.07 Shareholder vote results | 0001662774-25-000034 |
| 2025-05-1312:40 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001662774-25-000032 |
| 2025-05-1312:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001662774-25-000031 |
| 2025-04-2320:00 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001662774-25-000025 |
| 2025-03-2420:07 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001662774-25-000012 |
| 2025-03-2420:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001662774-25-000011 |
| 2024-11-1411:55 ET | 8-K | 8.01 Other events | 0001662774-24-000013 |
| 2024-11-1302:17 ET | SC 13D | Ownership report, active investor | 0001193125-24-257646 |
| 2024-11-1322:09 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001662774-24-000011 |
| 2024-11-1321:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001662774-24-000010 |
| 2024-08-1320:11 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001662774-24-000005 |
| 2024-08-1320:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001662774-24-000004 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.